PLA2G4A and atherosclerosis: Furthermore, IKKβ knockout in VSMCs induced by U0126 and SB202190 (inhibitors of p42/p44 MAPK) inhibited cytosolic phospholipase A2 (cPLA2) expression, which exacerbated the atherosclerosis-related vascular inflammation [78].